packageLinagliptin
linagliptin
Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).
Information
Linagliptin is a DPP-4 inhibitor used to lower blood sugar in adults with type 2 diabetes, available alone or in fixed oral combinations with other glucose-lowering drugs. It is approved and authorised in the European Union and is widely used as an oral anti-diabetic medicine.
Summary written by glm-5.3-flash from Wikidata Q909745 and the WHO ATC classification and the EMA medicines list; not checked by a person.
| name: | linagliptin |
| ATC codes: | A10BH05 |
| DrugBank: | DB08882 |
| PubChem CID: | 10096344 |
| ChEBI: | 68610 |
| Wikidata: | Q909745 |
| formula: | C25H28N8O2 |
| molar mass: | 472.553 g/mol (PubChem CID 10096344) |
| logP: | 1.9 (Drugs.Common 25.09, not verified) |
Parameters
| Type | Name | Default | Description |
|---|---|---|---|
| String | name (from PartialSubstance) | "" | INN / common name |
| String[:] | atcCodes (from PartialSubstance) | fill("", 0) | all WHO ATC codes of the drug |
| String | drugbankId (from PartialSubstance) | "" | e.g. DB00758 |
| String | pubchemCid (from PartialSubstance) | "" | PubChem compound id |
| String | chebiId (from PartialSubstance) | "" | ChEBI id (number) |
| String | wikidataId (from PartialSubstance) | "" | e.g. Q410238 |
| String | formula (from PartialSubstance) | "" | molecular formula |
| Modelica.Units.SI.MolarMass | M (from PartialSubstance) | 0 | molar mass; 0 = unknown |
| Real | logP (from PartialSubstance) | Modelica.Constants.inf | octanol-water partition coefficient (log10); inf = unknown |